Items Tagged ‘breast cancer’
October 18, 2021
By Susan Murphy 
When Michelle Ewy, 38, received an opportunity at Mayo Clinic to get her DNA tested for genetic mutations related to breast and ovarian cancers, and other cancers and diseases, she jumped at the chance. “I wasn’t thinking much of what the outcome would be because there has not been a prevalence of breast or ovarian […]
Tags: BRCA2, breast cancer, Dr. Konstantinos Lazaridis, Genetic Counseling, Genetic Testing, ovarian cancer, Teresa Kruisselbrink, whole exome sequencing
August 17, 2020
Mayo Clinic and Middlesex Health partner to transform genetic cancer research
By Susan Murphy
By Alyson Gonzalez What began as an inquiry sparked during a research brainstorming session, evolved into meaningful collaboration for a community cancer center in Connecticut. Through the Mayo Clinic Care Network relationship, Middlesex Health and Mayo Clinic are working together to improve the lives of cancer patients and their families through impactful research. Approximately one […]
Tags: breast cancer
August 12, 2020
Could population genetic screening improve public health?
Hereditary BRCA-related breast and ovarian cancer, Lynch syndrome and familial hypercholesterolemia are estimated to be relatively prevalent in the general population but poorly found using traditional risk screening. In a typical medical practice, genetic testing for these conditions is based on personal or family history, ethnic background or other demographic characteristics, that may not always […]
Tags: #Familial hypercholesterolemia, breast cancer, Dr. Matthew Ferber, lynch syndrome, mayo clinic, Mayo Clinic Center for Individualized Medicine, ovarian cancer, population health genomics, Research
September 25, 2019
The BEAUTY of it: award recognizes personalized medicine approach for breast cancer
A Mayo Clinic research team supported by the Center for Individualized Medicine is making significant breakthroughs — and gaining recognition for them. The Breast Cancer Genome-Guided Therapy (BEAUTY) project has received the 2019 Mayo Clinic Team Science Award, given for interdisciplinary work that substantially advances Mayo’s research. The award cites BEAUTY’s discoveries about breast tumor […]
Tags: #targeted therapies, BEAUTY trial, breast cancer, center for individualized medicine, chemotherapy, chemotherapy-resistant breast cancer, Dr. Judy Boughey, Dr. Liewei Wang, Dr. Matthew Goetz, Genetics, genomics, individualized medicine
August 29, 2019
Gerstner awards boost research into rheumatoid arthritis, breast cancer
Creating tools to identify optimal treatments for rheumatoid arthritis and breast cancer are focuses of the 2019 Gerstner Family Career Development Awards. This year’s awardees are Elena Myasoedova, M.D., Ph.D., a rheumatologist at Mayo Clinic’s Minnesota campus and Bhavika Patel, M.D., a radiologist at Mayo’s Arizona campus. Both researchers seek to apply data centric approaches […]
Tags: #Artificial Intelligence, #personalized therapies, biomarkers, breast cancer, center for individualized medicine, circulating tumor DNA, Dr. Bhavika Patel, Dr. Elena Myasoedova, Genetics, genomics, Gerstner Family Career Development Awards, mayo clinic
July 18, 2019
Targeting therapy to each patient’s unique cancer
By Sharon Rosen 
Article by Sara Damore As DNA sequencing technology helps bring genetic factors driving disease into focus, researchers have developed new cancer therapies to target a patient’s unique cancer, especially for those who do not respond to standard therapy. Funda Meric-Bernstam, M.D., a physician-scientist at MD Anderson Cancer Center will speak on Decision Support for Precision […]
Tags: #CIMCon19, #Mayo Cllinic, breast cancer, center for individualized medicine, Dr. Alan Bryce, Dr. Funda Meric-Bernstam, Genetic Sequencing, Genetic Testing, Individualizing Medicine Conference 2019, lymphoma, MD Anderson, Melanoma
July 9, 2019
Mayo experts provide insights into how genes affect medication response
By Sharon Rosen
Pharmacogenomics – how a person’s genes affect medication response – is touching virtually every area of medical care. Findings from the Mayo Clinic RIGHT study (Right Drug, Right Dose, Right Time–Using Genomic Data to Individualize Treatment) showed that 99% of participants had at least one genetic variant that may affect their response to medications. […]
Tags: #addiction, #anti-seizure medication, #Center for Individualized Mediicine, #Dr. Lauren Cornell, #Dr. Sanjay Bagaria, #Dr. William Freeman, #Dr. William Palmer, #drug-gene interactions, #epilepsy, #estrogen receptor positive breast cancer, #medical education, #neurological diseases
June 28, 2019
Can BioBanks Help Close Gaps in Health Outcomes?
By definition, personalized medicine requires diversity. One-size-fits-all doesn’t work for every individual, especially members of groups that are medically underserved. In collaboration with Arizona State University and Mountain Park Health Center (MPHC) in Phoenix, Mayo Clinic’s Center for Individualized Medicine has created a biobank to enhance the diversity of Mayo’s medical research. Sangre Por Salud (Spanish for […]
Tags: #Arizona State University, #diabetes, #disease risk, #Dr. Richard Caselli, #Giovanna Moreno Garzon, #Health Disparities, #high blood pressure, #Mayo Clinic Biobank, #Mountain Park Health Center, #obesity, #Sangre Por Salud, #underserved populations
June 3, 2019
Identifying hereditary cancer risk: genetic testing can lead to better screening, earlier treatment
By Sharon Rosen
Do you have family members who have been diagnosed with gastrointestinal, breast or ovarian cancer? According to a recent Mayo Clinic study, nearly 5% to 10% of these cancers can be hereditary. That’s why it is important to share your family medical history with your physician, who can determine if you and your family members […]
Tags: #cancer risk, #Center for Individualized Mediicine, #gastrointestinal cancer, breast cancer, colorectal cancer, Dr. Niloy "Jewel" Samadder, Genetic Testing, genomics, hereditary cancer, lynch syndrome, mayo clinic, Mayo Clinic Proceedings
May 29, 2019
By Sharon Rosen
Amidst the demands of providing care for patients with cancer, it can be challenging for oncologists and their care teams to keep up with the rapidly evolving field of genomics. Practical ways to apply the latest precision medicine discoveries is the focus of this year’s Individualizing Medicine Conference: Precision Cancer Care through Immunotherapy and Genomics, […]
Tags: #CAR T-cell therapy, #CIMCon19, biliary cancer, breast cancer, center for individualized medicine, Dr. Alan Bryce, familial cancer syndromes, hematologic cancers, immunotherapies, Individualizing Medicine Conference 2019, Lung Cancer, lymphoma